1Scott RC, Surtees RA, Neville BG. Status epilepticus: pathophysiology,epidemiology, and outcomes[J ]. Arch Dis Child. 1998,79( 1 ):73～77
2Eriksson KJ, Koivikko MJ.Status epilepticus in children: aetiology treatment and outcome[J]. Dev Med Child Neurol, 1997,39(10) :652～658
3Singhi S, Banerjee S, singhi P. Refractory status epilepticus in children:role of continuous diazepam infusion[J]. J Child Neurol, 1998,13( 1 ):23 ～ 26
4Starreveld E, Starrveld AA.. Status epilepticus. Current concepts and management [ J ]. Can Fam physician. 2000,46:1 817～ 1 823
5Yoshikawa H, Yamazaki S, Abe T, et al. Midazolam as a first-line agent for status epilepticus in children [J ]. Brain Dev. 2000,22 (4):239～ 242
6Lohr A Jr, Werneck LC. Comparative non - randomized study with midazolam versus thiopental in children with refractory status epilepticus[J ]. Arq Neuropsiquiatr, 2000,58 (2A): 282～ 287
7Kahriman M, Minecan D, Kutluay E, et al. Efficacy of topiramate in children with refractory status epilepticus [ J ]. Epilepsia, 2003, 44(10):1 353～1 356
